Related Experiment Video
Updated: Jul 2, 2026
04:19
Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates
1University of Maryland School of Medicine, 10 South Pine Street, MSTF 8-34, Baltimore, MD 21201, USA. mhochber@umaryland.edu
Current Osteoporosis Reports
|August 30, 2008
Summary
Bisphosphonates effectively reduce vertebral fractures in osteoporosis patients. However, their effectiveness in preventing nonvertebral and hip fractures varies, necessitating careful drug selection for comprehensive osteoporosis management.
Area of Science:
- Bone Metabolism and Endocrinology
- Pharmacology and Therapeutics
Background:
- Osteoporosis is a skeletal disorder marked by low bone mass and tissue deterioration, increasing fracture risk.
- Fractures are categorized into vertebral and nonvertebral types, with the latter including hip, pelvis, and limb fractures.
- Existing osteoporosis drugs show varied efficacy in reducing radiographic vertebral versus nonvertebral fractures.
Purpose of the Study:
- To summarize current data on nonvertebral and hip fracture risk reduction by N-containing bisphosphonates.
- To compare the efficacy of alendronate, ibandronate, risedronate, and zoledronic acid in reducing fractures.
- To analyze comparative efficacy using adjusted indirect comparison methods.
Main Methods:
- Review of currently available data on bisphosphonates for osteoporosis treatment.
- Focus on N-containing bisphosphonates: alendronate, ibandronate, risedronate, and zoledronic acid.
- Utilized adjusted indirect comparisons to analyze comparative efficacy.
Main Results:
- All reviewed bisphosphonates reduce radiographic vertebral fractures.
- Efficacy in reducing nonvertebral and hip fractures differs among the agents.
- Comparative analysis highlights varying effectiveness in fracture risk reduction.
Conclusions:
- N-containing bisphosphonates demonstrate variable efficacy in preventing nonvertebral and hip fractures.
- Selection of bisphosphonate therapy should consider specific fracture risk reduction profiles.
- Further comparative studies are warranted to optimize osteoporosis treatment strategies.
Related Concept Videos
01:27Fractures: Bone Repair
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
01:28Urinary Tract Calculi V: Nursing Management
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...